Small-cap stock jumps 8% after Q2 Results 2026 | Will the rally continue? Target, stop-loss

The company also recorded a 10.09% YoY growth in overall sales volume during the quarter, reflecting resilient business performance and sustained demand across its key packaging segments.On a segment-wise basis, pharma packaging emerged as a key growth driver, registering a robust volume growth of 26.30% YoY in Q2 FY27. Food and FMCG packaging, including Q-Pack, also delivered strong growth of 23.70%, supported by healthy demand.

Meanwhile, the paints packaging segment reported steady volume growth of 8.61%. However, the lubricants packaging segment witnessed a 12.32% decline in volume during the quarter. The strong growth in Food & FMCG and Pharma Packaging, supported by steady performance in Paints Packaging, more than offset the moderation in Lubricants Packaging, enabling the Company to achieve an overall sales volume growth of 10.08% year-on-year during Q2 FY2027.

The company's operating performance also remained robust, with EBITDA growing 29.80% year-on-year to ₹51.27 crore in Q2 FY27. The growth in revenue, profitability and operating earnings highlights the company's strong performance during the September quarter. "We delivered pharmaceutical performance in spite of turbulent times”. Announcing the results, Chairman & Managing Director Mr J Lakshmana Rao said: The operating environment during the quarter remained challenging, marked by sharp increases in raw material prices and constraints in material availability arising from geopolitical disruptions.

Mold-Tek Packaging share price outlook Sumeet Bagadia, Executive Director at Choice Broking, said that investors who are already holding Mold-Tek Packaging shares can continue to hold the stock with a long-term perspective. However, fresh investors should avoid chasing the stock at current levels and wait for a dip to enter. “At the current market price (CMP) of ₹312, the stock offers an upside potential towards the target price of ₹370.

Existing investors can maintain a stop-loss at ₹275 to manage downside risk. Overall, our recommendation is to hold for existing investors and wait for a correction before fresh entry,” Bagadia said.Meanwhile, Mahesh M Ojha, VP Research & Business Development at Kantilal Chhaganlal Securities, believes that is showing potential for further upside. Investors can maintain a stop-loss at ₹280, while the stock has an upside target of ₹328, ₹340 and ₹360+.“Investors are recommended maintaining a positive outlook on the stock while adhering to the prescribed stop-loss to manage downside risk,” Ojha added.